|
|
|
|
LEADER |
03414nam a22004935i 4500 |
001 |
978-3-642-27540-1 |
003 |
DE-He213 |
005 |
20151116135004.0 |
007 |
cr nn 008mamaa |
008 |
120120s2012 gw | s |||| 0|eng d |
020 |
|
|
|a 9783642275401
|9 978-3-642-27540-1
|
024 |
7 |
|
|a 10.1007/978-3-642-27540-1
|2 doi
|
040 |
|
|
|d GrThAP
|
050 |
|
4 |
|a QD415-436
|
072 |
|
7 |
|a PNN
|2 bicssc
|
072 |
|
7 |
|a SCI013040
|2 bisacsh
|
082 |
0 |
4 |
|a 547
|2 23
|
245 |
1 |
0 |
|a Fragment-Based Drug Discovery and X-Ray Crystallography
|h [electronic resource] /
|c edited by Thomas G. Davies, Marko Hyvönen.
|
264 |
|
1 |
|a Berlin, Heidelberg :
|b Springer Berlin Heidelberg,
|c 2012.
|
300 |
|
|
|a XII, 228 p.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|b PDF
|2 rda
|
490 |
1 |
|
|a Topics in Current Chemistry,
|x 0340-1022 ;
|v 317
|
505 |
0 |
|
|a D. A. Erlanson Introduction to Fragment-Based Drug Discovery -- T. G. Davies Ian J. Tickle Fragment Screening Using X-Ray Crystallography -- S. Roughley L. Wright P. Brough A. Massey R. E. Hubbard Hsp90 Inhibitors and Drugs from Fragment and Virtual Screening -- D. F. Wyss Y.-S. Wang H. L. Eaton C. Strickland J.s H. Voigt Z. Zhu A. W. Stamford Combining NMR and X-ray Crystallography in Fragment-Based Drug Discovery: Discovery of Highly Potent and Selective BACE-1 Inhibitors -- M. Hennig A. Ruf Walter HuberCombining Biophysical Screening and X-Ray Crystallography for Fragment-Based Drug Discovery -- E. Valkov T. Sharpe M. Marsh Sa. Greive M. Hyvönen Targeting Protein–Protein Interactions and Fragment-Based Drug Discovery -- J.h D. Bauman D. Patel E. Arnold Fragment Screening and HIV Therapeutics -- D. Rognan Fragment-Based Approaches and Computer-Aided Drug Discovery.
|
520 |
|
|
|a D. A. Erlanson Introduction to Fragment-Based Drug Discovery T. G. Davies Ian J. Tickle Fragment Screening Using X-Ray Crystallography S. Roughley L. Wright P. Brough A. Massey R. E. Hubbard Hsp90 Inhibitors and Drugs from Fragment and Virtual Screening D. F. Wyss Y.-S. Wang H. L. Eaton C. Strickland J.s H. Voigt Z. Zhu A. W. Stamford Combining NMR and X-ray Crystallography in Fragment-Based Drug Discovery: Discovery of Highly Potent and Selective BACE-1 Inhibitors M. Hennig A. Ruf Walter HuberCombining Biophysical Screening and X-Ray Crystallography for Fragment-Based Drug Discovery E. Valkov T. Sharpe M. Marsh Sa. Greive M. Hyvönen Targeting Protein–Protein Interactions and Fragment-Based Drug Discovery J.h D. Bauman D. Patel E. Arnold Fragment Screening and HIV Therapeutics D. Rognan Fragment-Based Approaches and Computer-Aided Drug Discovery.
|
650 |
|
0 |
|a Chemistry.
|
650 |
|
0 |
|a Pharmaceutical technology.
|
650 |
|
0 |
|a Organic chemistry.
|
650 |
|
0 |
|a Crystallography.
|
650 |
1 |
4 |
|a Chemistry.
|
650 |
2 |
4 |
|a Organic Chemistry.
|
650 |
2 |
4 |
|a Crystallography.
|
650 |
2 |
4 |
|a Pharmaceutical Sciences/Technology.
|
700 |
1 |
|
|a Davies, Thomas G.
|e editor.
|
700 |
1 |
|
|a Hyvönen, Marko.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|
776 |
0 |
8 |
|i Printed edition:
|z 9783642275395
|
830 |
|
0 |
|a Topics in Current Chemistry,
|x 0340-1022 ;
|v 317
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1007/978-3-642-27540-1
|z Full Text via HEAL-Link
|
912 |
|
|
|a ZDB-2-CMS
|
950 |
|
|
|a Chemistry and Materials Science (Springer-11644)
|